Nicotinic acetylcholine receptors (AChRs) containing ␣6 subunits are typically found at aminergic nerve endings where they play important roles in nicotine addiction and Parkinson's disease. ␣6* AChRs usually contain ␤3 subunits. ␤3 subunits are presumed to assemble only in the accessory subunit position within AChRs where they do not participate in forming acetylcholine binding sites. Assembly of subunits in the accessory position may be a critical final step in assembly of mature AChRs. Human ␣6 AChRs subtypes were permanently transfected into human tsA201 human embryonic kidney (HEK) cell lines. ␣6␤2␤3 and ␣6␤4␤3 cell lines were found to express much larger amounts of AChRs and were more sensitive to nicotine-induced increase in the amount of AChRs than were ␣6␤2 or ␣6␤4 cell lines. The increased sensitivity to nicotineinduced up-regulation was due not to a ␤3-induced increase in affinity for nicotine but probably to a direct effect on assembly of AChR subunits. HEK cells express only a small amount of mature ␣6␤2 AChRs, but many of these subunits are on the cell surface. This contrasts with Xenopus laevis oocytes, which express a large amount of incorrectly assembled ␣6␤2 subunits that bind cholinergic ligands but form large amorphous intracellular aggregates. Monoclonal antibodies (mAbs) were made to the ␣6 and ␤3 subunits to aid in the characterization of these AChRs. The ␣6 mAbs bind to epitopes C-terminal of the extracellular domain. These data demonstrate that both cell type and the accessory subunit ␤3 can play important roles in ␣6* AChR expression, stability, and up-regulation by nicotine.
Nicotinic acetylcholine receptors (AChRs) are composed of five homologous subunits (Lindstrom, 2000; Sine and Engel, 2006) . Heteromeric neuronal AChRs contain two ACh binding sites formed by the interfaces of ␣2, ␣3, ␣4, or ␣6 subunits with ␤2 or ␤4 subunits. The fifth "accessory" subunit does not participate in forming an ACh binding site but contributes to the channel lining and influences assembly, transport, and function of AChRs. The accessory position is often occupied by ␤2 or ␤4 subunits, but ␣4 can also assemble there (Kuryatov et al., 2005) . ␤3 and ␣5 can assemble only in this position.
AChRs containing ␣6 subunits (␣6* AChRs) comprise minor subtypes selectively localized in the endings of aminergic neurons (Zoli et al., 2002; Champtiaux et al., 2003; Gotti et al., 2005b) . ␣6* AChRs contribute to nicotine-stimulated dopamine release from striatal synaptosomes (Azam and McIntosh, 2005) , are selectively lost in animal models of Parkinson's disease, and are potential targets for Parkinson's disease therapy (Quik and McIntosh, 2006) . ␣6* AChRs are the major non-␣4* AChR expressed in the optic tract (Gotti et al., 2005b) . ␤3 subunits are usually found in ␣6* AChRs, and knockout of ␤3 reduces but does not eliminate expression of ␣6* AChRs (Gotti et al., 2005a) .
Nicotine up-regulates the amount of brain AChRs (Flores et al., 1992) . Nicotine treatment has been reported to both increase (Parker et al., 2004) and decrease the amount of brain ␣6* AChRs (Lai et al., 2005; McCallum et al., 2006; Mugnaini et al., 2006) . In transfected HEK cell lines, nicotine applied overnight increases the amount of human ␣3␤2 and ␣4␤2 AChRs but not ␣3␤4 or ␣4␤4 AChRs, primarily by acting as a pharmacological chaperone to promote assembly of AChRs Kuryatov at al., 2005; Sallette et al., 2005; Corringer et al., 2006) . Putative assembly intermediates the size of ␣4␤2␣4␤2 tetramers have been identified that could assemble with accessory subunits in a final step to produce mature AChRs (Kuryatov et al., 2005) . Nic-otine also contributes to up-regulation by increasing the lifetime of surface membrane AChRs (Kuryatov et al., 2005) . Nicotine applied to transfected HEK cell lines for 5 days up-regulated rat AChRs containing ␣2, ␣3, or ␣4 in combination with ␤2 or ␤4 subunits (Xiao and Kellar, 2004) .
It has been challenging to express ␣6 AChRs . In Xenopus laevis oocytes, human ␣6␤4 AChRs were functional, and ␣6␤4␤3 AChRs were expressed at a higher level (Kuryatov et al., 2000) . Although coexpression of ␣6 and ␤2 produced abundant ACh binding sites, they were on amorphous aggregates within the oocytes. Chimeric subunits with the extracellular domain of ␣6 and the remainder of either ␣3 or ␣4 subunits assembled efficiently with either ␤2 or ␤4 subunits in oocytes (Kuryatov et al., 2000) . In human BOSC 23 cells, chicken ␣6␤2 were AChRs expressed at a lower level than ␣4␤4 (Fucile et al., 1998) . Attempts to express human ␣6␤2, ␣6␤2␤3, ␣6␤4, and ␣6␤4␤3 AChRs in transfected SH-EPI cell lines were unsuccessful, but the ␣6␤4␤3␣5 subunit combination exhibited cholinergic ligand binding (Grinevich et al., 2005) . Chimeric subunits with the extracellular domain of ␣6 and the remainder of ␣4 formed functional AChRs in HEK cell lines (Evans et al., 2003) . ␣6 subunits are closely related in sequence to ␣3 subunits, and ␤3 subunits are closely related to ␣5 subunits (Lindstrom, 2000; Le Novere et al., 2002) . Permanently transfected HEK tsA201 cells have been used to express human ␣3* and ␣4* AChRs Nelson et al., 2001; Kuryatov et al., 2005) . ␣3␤2 AChRs assembled efficiently in X. laevis oocytes (Wang et al., 1996; Gerzanich et al., 1998) , but in HEK cells they do not assemble efficiently unless up-regulation is induced by nicotine or culture at low temperatures . Coexpression in HEK cells of ␣3␤2 with ␣5 increases expression, but coexpression of ␣3␤4 with ␣5 somewhat decreases expression . In oocytes, ␣5 subunits alter desensitization, pharmacology, and Ca 2ϩ permeability of ␣3 AChRs (Gerzanich et al., 1998) , so it might be expected that ␤3 subunits would similarly have substantial effects on ␣6 AChRs.
Here, we report the production of stably transfected tsA201 HEK lines expressing four subtypes of human ␣6* AChRs and their initial characterization. Expression of ␤3 with either ␣6␤2 or ␣6␤4 subunit combinations increased the amount of AChRs expressed and increased their sensitivity to up-regulation by nicotine. mAbs were made to human ␣6 and ␤3 subunits to aid in the characterization of these AChRs.
Materials and Methods
cDNAs. Human ␣6, ␤2, and ␤4 cDNAs were cloned in this laboratory as described previously (Anand and Lindstrom, 1990; Gerzanich et al., 1997; Kuryatov et al., 2000) . Human ␤3 was obtained from Christopher Grantham (Janssen Research Foundation, Beerse, Belgium) and subcloned into pcDNA 3.1/Zeo(ϩ) for transfection. ␣6 was subcloned into pEF6/blasticidin(ϩ). ␤2 and ␤4 were separately cloned into pRc-CMV/Geneticin(ϩ). All vectors were obtained from Invitrogen (Carlsbad, CA).
Cell Line Culture and Transfection. Human embryonic kidney tsA201 cell lines (Margolskee et al., 1993) were maintained in Dulbecco's modified Eagle's medium (DMEM, high glucose; Invitrogen) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT), 100 units/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine at 37°C, 5% CO 2 at saturating humidity in a water jacket incubator. HEK cells were transfected using the FuGENE 6 DNA transfection kit (Roche Diagnostics, Indianapolis, IN), according to the manufacturer's instructions, with human ␣6 (pEF6/blasticidin), human ␤2 [pRc-CMV/Geneticin(ϩ)], or human ␤4 [pRc-CMV/Geneticin(ϩ)]. ␣6␤2 was created by transfecting HEK cells with ␣6 and ␤2 cDNAs. ␣6␤4 was created by transfecting HEK cells with ␣6 and ␤4 cDNAs. Selective pressure for cells containing ␣6 was applied with 5 g/ml blasticidin starting 72 h after transfection. ␤2 and ␤4 cell lines were similarly selected with 600 g/ml G418 (Geneticin). ␣6␤2 and ␣6␤4 AChRs were assayed for expression and screened by [ 3 H]epibatidine binding. Stably transfected ␣6␤4 and ␣6␤2 lines were cotransfected with human ␤3 [pcDNA 3.1/Zeocin(ϩ)] to produce ␣6␤4␤3 and ␣6␤2␤3 AChRs. Selective pressure for cell lines containing ␤3 was applied using 500 g/ml Zeocin starting 72 h after transfection. AChRs containing ␤3 were selected for high expression based on liquid phase radioimmunoassays. ␤3-transfected cell lines were plated in serial dilution on Costar 96-well plates (Corning Life Sciences, Acton, MA). Surviving colonies were plated individually to Costar 35-mm culture plates and then grown to confluence. Cells were detached with ice-cold DMEM and extracted as described above into a 1.5-ml microcentrifuge tube. AChRs were incubated with 2.5 nM [
3 H]epibatidine and 5 l of ␤3 antiserum, acquired from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), for 1 to 2 h at room temperature. AChRs were precipitated by secondary antibody incubation with rabbit anti-goat antiserum for 1 to 2 h at room temperature and then pelleted at 13,000g for 10 min. Pellets were washed three times with 1 ml of 0.5% Triton X-100 in PBS ϩ 10 mM NaN 3 to remove excess radioligand. Washing solution was aspirated from the pellet before adding 50 l of 0.1 N NaOH to solubilize the pellet. One milliliter of Optiphase SuperMix (PerkinElmer Life and Analytical Sciences, Boston, MA) was added to each sample. Samples with scintillation fluid were set on rotation for 1 h at room temperature before counting in a 1450 Microbeta Trilux liquid scintillation and luminescence counter (PerkinElmer Life and Analytical Sciences).
Membrane Fraction [ 3 H]Epibatidine Binding. To assess relative expression levels across ␣6 containing AChR types expressed in HEK cells, stably transfected HEK cells were grown to confluence on Costar 35-mm tissue culture plates (approximately 1 ϫ 10 6 cells/ plate) and then detached by ice-cold DMEM and collected by centrifugation at 500g. Cells were washed once with 1 ml of buffer A (50 mM NaPO 4 , pH 7.5, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, 5 mM benzamidine, 15 mM iodoacetamide, and 2 mM phenylmethylsulfonyl fluoride), pelleted by centrifugation at 13,000g, and then resuspended in buffer A. Cells in buffer A were incubated with 2 nM [ 3 H]epibatidine for 30 min at room temperature with agitation. Cell membrane fractions were washed three times with PBS ϩ 10 mM NaN 3 on glass filters (GF/F; Whatman, Maidstone, UK) pretreated with 1% polyethylenimine for 1 h and dried on blotting paper. Filters containing AChRs bound to radioligands were counted in 1.5-ml microcentrifuge tubes using 1 ml of Optiphase SuperMix scintillation fluid in a 1450 Microbeta Trilux liquid scintillation counter (PerkinElmer Life and Analytical Sciences). Results were standardized to the wet weight of the cells after the first wash in buffer A.
Previously Used Antisera and Monoclonal Antibodies. A rat antiserum to bacterially expressed ␣6 subunit sequences (excluding the transmembrane domains) was raised as described by Kuryatov et al. (2000) . The rat mAb 210 binds to the main immunogenic region on native ␣1, ␣3, and ␣5 (Lindstrom, 2000) and ␤3 (A. Kuryatov and J. Lindstrom, unpublished data) . The rat mAb 295 binds to the extracellular surface of AChR ␤2 subunits when they are assembled with ␣ subunits (Lindstrom, 2000; Kuryatov et al., 2005) . The mouse mAb 337 was raised to bacterially expressed human ␤4 subunit large cytoplasmic domain (Nelson et al., 2001) .
Preparation of New mAbs. Human ␣6 and ␤3 subunits lacking the transmembrane domains of these subunits were constructed in the pET-26b(ϩ) vector (Novagen, Madison, WI) and expressed in bacteria. ␣6 subunits were expressed in oocytes and extracted with ␣6 AChRs 2% Triton X-100 as described in Kuryatov et al. (2000) . The extracts were incubated with mAb 295 coupled to CH-Sepharose (GE BALB/c mice were immunized and then boosted at 3-week intervals with 40 g per mouse of bacterially expressed subunit constructs lacking the transmembrane domains of the subunits in TiterMax (TiterMax USA, Inc., Norcross, GA). The titers were monitored by test bleeds against corresponding subunits in enzymelinked immunosorbent assay. Five days after a final boost with antigen, the harvested splenic lymphocytes (ϳ10 8 ) from the animal with the highest titers were fused with SP2/0 myeloma cells (1 ϫ 10 8 ) using 50% polyethylene glycol (Eastman Kodak, Rochester, NY) and inoculated into 24 96-well plates (Costar 3595; Corning Life Sciences, Acton, MA).
Initial screening was done by enzyme-linked immunosorbent assay as described previously (Kuryatov et al., 2005) . To eliminate mAbs that cross-reacted with closely related subunits, the crossreaction of mAbs with a subunit that has the highest homology with the immunogen was tested (␣3 in the case of ␣6 and ␣5 in the case of ␤3). mAbs that could bind both denatured subunits and native AChRs were selected using [
3 H]epibatidine-labeled native AChRs in radioimmunoassays and then cloned by a limiting dilution method.
To determine titers of antibody to native AChRs, various concentrations of mAbs were incubated in 100 l of buffer C containing a 0.5 nM concentration of AChRs and 1.5 nM [
3 H]epibatidine. After overnight at 4°C, 25 l of zysorbin (Invitrogen) was added into each tube, followed by a 30-min incubation at room temperature. The material in the tubes was diluted into 1 ml with 0.5% Triton X-100 in PBS (TPBS). After a 5-min centrifugation at 4000g, the supernatant was removed by aspiration. The pellet was washed with 1 ml of TPBS and then suspended in 100 l of 0.1 N NaOH. The suspension was mixed with 900 l of Optiphase SuperMix scintillation fluid (PerkinElmer Life and Analytical Sciences). The amount of bound [ 3 H]epibatidine was determined by liquid scintillation counting for 5 min. Background was determined by substituting normal mouse serum for the mAb.
To determine cross-reactivity of mAbs to related subunits with dot blot immunoassay, 167 ng/well of various bacterially expressed human AChR subunits was gravity-blotted onto prewetted nitrocellulose membranes in 100 l of TPBS (20 mM Tris-HCl and 500 mM NaCl, pH 7.5) using a Bio-Dot apparatus (Bio-Rad, Hercules, CA). Then, 300 l of TPBS containing 1% bovine serum albumin was applied into each well to block nonspecific-antibody binding in subsequent steps. After blocking, the membranes were incubated for 1 h with a 1 g/ml mAb or a 1:500 dilution of rat antiserum specific for the different subunits as controls. The membranes were rinsed three times with TPBS containing 0.05% Tween 20 and then probed for 1 h with a 1:2000 dilution of biotinylated goat anti-mouse IgG (Kirkegaard and Perry Laboratories, Gaithersburg, MD), followed by a 1-h incubation with peroxidase-labeled streptavidin (Kirkegaard and Perry Laboratories), and a final incubation in peroxidase substrate to visualize antibody binding. A 1:2000 dilution of biotinylated goat anti-rat IgG (Kirkegaard and Perry Laboratories) was used under conditions where rat antiserum was used as the first antibody instead of a mAb. Membranes were washed five times with TPBS containing 0.05% Tween 20 and then two times with TPBS before substrate addition.
AChR Extraction from HEK Cells with Triton X-100. HEK cells expressing AChRs were grown in Costar 10-or 15-cm plates and then up-regulated by exposure to 100 M nicotine overnight at 37°C. Cells were detached using 5 or 10 ml of ice-cold DMEM and then collected via centrifugation at 500g. DMEM was aspirated from the pellet. Cells were suspended with 1 ml of buffer A and then transferred to a 1.5-ml Eppendorf microcentrifuge tube and collected via centrifugation at 13,000g for 15 min at 4°C. Buffer A was aspirated from the pellets, which were then weighed. AChRs were extracted with 3 volumes of the pellet weight using buffer C (buffer A with 2% Triton X-100). The suspension was gently rotated for 1 h at room temperature. Cell debris was pelleted by centrifugation at 13,000g for 15 min at 4°C. Supernatant containing AChRs in Triton X-100 was removed to new 1.5-ml centrifuge tubes and used immediately, keeping samples at 0-4°C.
Western Blots. AChRs were extracted with 2% Triton X-100 as described above from either HEK cell lines or X. laevis oocytes expressing either ␣6␤2, chimeric ␣6/␣3 ␤2, or chimeric ␣3/␣6 ␤2 AChRs. Samples were electrophoresed in precast 10% polyacrylamide Tris-glycine gels (Novex, San Diego, CA) under reducing conditions. Western transfer was done using a semidry electroblotting chamber (Semi-Phor; Hoeffer, San Francisco, CA) to Trans-Blot Medium polyvinylidene difluoride membrane (Bio-Rad). Blots were quenched with 5% Carnation dried milk in 0.5% Triton X-100 in PBS, 10 mM NaN 3 . mAbs were used as indicated at 1:1000 dilution in milk blocking solution. Blots were probed overnight at 4°C on a shaker followed by three washes with 0.5% Triton X-100 in PBS, 10 mM NaN 3 . Blots were then incubated with 2 nM 125 I-goat antimouse IgG (specific activity 2.5 ϫ 10 18 cpm/mol) overnight on a shaker at 4°C followed by three washes with TPBS. Autoradiography was done at Ϫ80°C with Kodak BioMax film using a Kodak MS screen (Eastman Kodak) for the indicated time periods.
Agonist Binding on Fixed Cells. Cells were plated onto Costar 96-well white with clear bottom plates and grown to 70% confluence. Nicotine was added to induce up-regulation of AChRs. Cells were incubated overnight at 37°C. Cells grown to confluence were exposed to 1 volume of 10% formalin added directly to the growth medium for 1 h at room temperature to fix the cells to the wells. Cells were washed free of agonist and formalin with 200 l of PBS ϩ 10 mM NaN 3 three times and stored at 4°C with 1 volume of PBS-NaN 3 until use. Agonists were applied at indicated concentrations with [
3 H]epibatidine at 2 nM. Binding was conducted at room temperature for 2 h with gentle agitation. Plates were again washed to remove unbound ligands as described above. [ 3 H]Epibatidine was eluted from the AChRs by 50 l of 0.1 N NaOH. Then, 200 l of Optiphase SuperMix (PerkinElmer Life and Analytical Sciences) scintillation fluid was added to each well. Plates were then shaken at room temperature for 1 to 2 h before scintillation counting. Comparison of the maximum number of epibatidine binding sites in all four cell lines after upregulation with nicotine revealed that in fixed cells 93 Ϯ 7% of the binding sites observed in membrane fragments were detected on fixed cells. Binding to fixed cells was faster and easier than using membrane fragments and avoided variation as a result of cells detaching during washing, which occurred without fixation.
Sucrose Density Gradients. A linear gradient maker was loaded with 5.7 ml each of 5 and 20% sucrose in 0.5% Triton X-100 to construct an 11.4-ml, linear 5 to 20% sucrose gradient. Gradients were built in Quick-Seal centrifuge tubes (Beckman Coulter, Inc., Fullerton, CA) (13 ϫ 51 mm). Then, 400 l of cell extract was combined with 2 l of extract of the electric organ from Torpedo californica (ϳ1 M ␣-bungarotoxin binding sites) for an internal size marker and loaded onto the top of each gradient. Gradients were centrifuged at 40,000 rpm for 16 h at 4°C in an XL-90 ultracentrifuge using an SW-41 rotor (Beckman Coulter, Inc.). After ultracentrifugation, the tubes were punctured, and fractions were collected from the bottom into mAb-coated Immulon flat-bottomed 4HBX wells (Thermo Electron Corporation, Waltham, MA) using a fraction collector set to collect 10 drops per well (approximately 130 l/well). The 96-well Immulon 4HBX plates were coated with mAb 295 to bind AChRs containing ␤2 or with mAb 338 to bind AChRs containing ␤4. Fractions were bound to their respective antibody overnight at 4°C with gentle agitation. After incubation, 30 l from each fraction was transferred onto an Immulon plate coated with mAb 210 to bind Torpedo californica AChRs, and 70 l of 2% Triton X-100 in buffer A was added. Solid phase radioimmunoassays were probed for 2 h at room temperature with agitation with 2 nM 125 I-␣-bungarotoxin to detect T. californica AChR binding on mAb 210 plates, or with 2 nM [ 3 H]epibatidine to detect ␣6* AChR binding on mAb 295 or mAb 338 plates. Then, plates were washed three times with TPBS. Radioligand was dissociated by denaturing the samples with 50 l of 0.1 N NaOH and transferred for counting into Costar 96-well white-walled plates containing 200 l of Optiphase SuperMix.
Determining ␤3 Incorporation. ␣6* and ␤3* cell lines were extracted as described above using Triton X-100 in buffer A. Extracts were aliquoted into different sets for liquid phase immunoprecipitation, total [
3 H]epibatidine binding, and mAb 210 agarose resin depletion. Sets aliquoted for mAb 210 agarose resin depletion were incubated with 20 l of agarose resin coated with mAb 210 in a total volume of 100 l along with 2 nM [ 3 H]epibatidine. These samples were incubated overnight at 4°C with constant agitation. Supernatant fluid was collected from samples after 5000g centrifugation for 5 min, and then AChRs were precipitated with mAb 338. All samples were denatured with 50 l of 0.1 N NaOH for 5 min and then shaken with 1 ml of Optiphase SuperMix for 2 h. ␤3 incorporation was calculated by the difference between the total and depleted samples over the total binding.
Binding of [ 3 H]Epibatidine to Cells.
Cells expressing ␣6* AChRs were grown in media as described above on 35-mm dishes. One day before assay, nicotine was added into the growth media at a final concentration of 10 M for ␤3-containing cells and 100 M for other cells. Binding to living cells attached to 35-mm plates was done in DMEM at 4°C for only 15 min with 1 nM [ 3 H]epibatidine to minimize ongoing up-regulation and penetration of quaternary amines inside the cells. To determine the internal pool of epibatidine binding sites, 1 mM of the membrane-impermeable quaternary amine methylcarbamylcholine was added together with 1 nM [ 3 H]epibatidine to inhibit binding to cell surface AChRs. Nonspecific labeling (around 1% of total) was determined by incubation with 100 M nicotine and subtracted from total binding. After incubation, the cells were detached using 1 ml of ice-cold PBS with 5 mM EDTA and washed three times with 1 ml of ice-cold PBS by centrifugation (5 min at 500g) in Eppendorf tubes. The washed pellets were dissociated with 100 l of 0.1 M NaOH, and bound radioactivity was determined in the same tubes using the scintillation counter with 1 ml per tube of scintillation fluid.
Results

Construction of Stably Transfected tsA201 HEK Cell
Lines Expressing ␣6␤2, ␣6␤2␤3, ␣6␤4, and ␣6␤4␤3 AChRs. First ␣6␤2 and ␣6␤4 lines were established. Then, these lines were transfected with ␤3 to produce lines expressing ␣6␤2␤3 and ␣6␤4␤3 AChRs.
Total amounts of AChRs expressed were measured by [ 3 H]epibatidine binding to cell membrane fractions (Fig. 1A) . Expression of ␣6␤2 AChRs (45 fmol/mg protein) was very low compared with ␣3␤2 (200 fmol/mg; Wang et al., 1998) or ␣4␤2 AChR HEK cell lines (900 fmol/mg; Kuryatov et al., 2005) . Coexpression with ␤3 doubled the amount of AChR, much as coexpression with ␣5 doubled the amount of ␣3␤2 AChRs . ␣6␤4 expression was twice that of ␣6␤2. Likewise, ␣3␤4 expression in a HEK line exceeded ␣3␤2 expression by 4-fold . The increased expression of ␤4-containing compared with ␤2-containing AChRs reflects less efficient assembly of ␤2 subunits as a result of a microdomain near the ACh binding site (Sallette et al., 2004) and results in increased sensitivity of ␤2-con- Binding was assayed under control conditions and after culture overnight in medium containing 100 M nicotine to maximally up-regulate the amount of AChR. B, cell surface AChRs were determined by measuring the fraction of 2 nM [ 3 H]epibatidine binding to intact cells which was inhibited by the presence of 10 mM methylcarbamylcholine. The tertiary amine epibatidine rapidly crosses the cell membrane to label AChRs both on the surface and interior of cells, but the quaternary amine methylcarbamylcholine crosses the membrane so slowly that during the 1-h assay it binds almost exclusively to AChRs on the cell surface (Kuryatov et al., 2005) . C, data were plotted to indicate the fraction of AChRs on the cell surface under control conditions and after up-regulation overnight by 100 M nicotine. Bars show measured values Ϯ S.E.M. for quadruplicate samples.
␣6 AChRs
taining AChRs to the molecular chaperone effects of nicotine, which selectively promotes increased assembly of ␤2-containing AChRs Kuryatov et al., 2005;  Fig. 1 ). Coexpression with ␤3 increased ␣6␤4 expression a further 6-fold. By contrast, coexpression of ␣5 with ␣3␤4 decreased expression by 30% .
Incubation with 100 M nicotine overnight increased the amount of ␣6* AChRs (Fig. 1A) . This increased ␣6␤2 AChRs 4-fold, ␣6␤2␤3 AChRs 3.3-fold, ␣6␤4 AChRs 3.2-fold, and ␣6␤4␤3 AChRs 1.5-fold. At the same time, up-regulation significantly increased surface expression in ␤2-containing cells (Fig. 1B) . After up-regulation a greater fraction of the AChRs was found inside the cells (Fig. 1C) . This was also observed after nicotine-induced up-regulation of ␣4␤2 AChRs (Kuryatov et al., 2005) . Nicotine acts as a molecular chaperone to rapidly promote assembly of new ␣4␤2 AChRs in the endoplasmic reticulum (Kuryatov et al., 2005; Sallette et al., 2005; Corringer et al., 2006) . Transport of ␣4␤2 AChRs to the surface through the Golgi apparatus for modification of glycosylation may be a rate-limiting step in surface expression. Similar processes may occur with ␣6* AChRs.
The time course of up-regulation by 100 M nicotine was similar for all of the cell lines (Fig. 2) . Up-regulation was half complete within 3 h and close to maximal by 24 h. This is similar to the kinetics of up-regulation of ␣3␤2 and ␣4␤2 AChRs in tsA201HEK cell lines Kuryatov et al., 2005) .
Raising mAbs to ␣6 and ␤3 Subunits. Mouse mAbs were raised to bacterially expressed human ␣6 and ␤3 subunits. Those mAbs that cross-reacted between subunits by dot blots of bacterially expressed subunits were eliminated, leaving six mAbs to ␣6 and one to ␤3, which were subunitspecific by this criterion (Fig. 3A) . mAb 376 reacted only on blots with denatured ␤3, not with native AChRs. The mAbs to ␣6 also reacted on Western blots with ␣6 subunits from AChRs expressed in HEK cell lines and showed no crossreaction with ␣3, ␣4, ␤2, or ␤4 subunits of AChRs expressed in these cell lines (Fig. 3B) . mAb 349 was the best for use on Western blots.
The relative amounts of ␣6 subunits in the four cell lines were compared by Western blotting (Fig. 3C) . The ␣6␤2 cell line expressed few native AChRs (Fig. 1A) and correspondingly contained few ␣6 subunits (Fig. 3C) . Thus, there were not large pools of unassembled ␣6 subunits in the ␣6␤2 line. The fact that transfection with ␤3 resulted in a greatly increased amount of ␣6 as seen in the ␣6␤2␤3 cell line suggests that unassembled ␣6 subunits and ␣6␤2 AChRs turn over rapidly and that the presence of ␤3 subunits permits the formation of ␣6␤2␤3 AChRs, which are much more stable and therefore much more ␣6 accumulates.
The transmembrane orientation of the epitopes of the ␣6 mAbs was determined by Western blots (Fig. 3D) . All six mAbs to ␣6 on Western blots recognized a chimera (␣3/6) with the extracellular domain of ␣3 and the remainder of ␣6, but not a chimera (␣6/3) with the extracellular domain of ␣6 and the remainder of ␣3 (Fig. 3D ). This indicates that the epitopes recognized by the mAbs are located C-terminal of the extracellular domain in the ␣6 subunit.
The six mAbs to bacterially expressed (denatured) ␣6 also immunoprecipitate native human ␣6 AChRs, with mAbs 338, 350, and 351 being the most potent (Table 1) . Three of these mAbs also cross-reacted weakly with AChRs from rat brains. This was tested using high (25 g) amounts of mAbs in a 200-l reaction mix containing 0.2 nM [ 3 H]epibatidinelabeled rat brain AChRs precipitable by mAb 295 to ␤2 subunits. Of these AChRs, 4% were bound by mAb 350, and approximately 0.25% was bound by mAbs 338 and 351.
Immunoadsorption demonstrated that ␤3 subunits were incorporated into ␣6 AChRs (Fig. 4) , as would be expected from the large increase of expression in the presence of ␤3 (Fig. 1) . The putative main immunogenic region (MIR) sequence 66-76 of human ␣1 subunits (KWNPDDYGGVK) is closely related to sequences on human ␣3 (KWNPSDYG-GAE), ␣5 (RWNPDDYGGIK), and ␤3 (RWNPDDYGGIH). mAb 210 was made to muscle type AChRs, competes for binding to them with other mAbs to the MIR, and also binds to denatured ␣1 (Lindstrom, 2000) . In addition, it binds very well to native human ␣3 AChRs , but it does not bind well to denatured ␣3. mAb 210 also binds to native but not denatured human ␣5 . mAb 210 exhibited low affinity for direct immunoprecipitation of ␣6␤2␤3 or ␣6␤4␤3 AChRs, but mAb 210 coupled to agarose efficiently adsorbed ␣6␤2␤3 and ␣6␤4␤3 AChRs. It did not bind ␣6␤2 or ␣6␤4 AChRs. Figure 4 shows that 40% of ␣6␤2␤3 and 60% of ␣6␤4␤3 AChRs precipitated by mAb 338 could be adsorbed by mAb 210 coupled to agarose. This probably underestimates the actual percentage of these AChRs, which contain ␤3 because of the low affinity of mAb 210 for ␤3 in these ␣6 AChRs. Because mAb 210 binds efficiently only to native ␣3, ␣5, and ␤3, but to both native and denatured ␣1, probably both the sequence, and, especially, the conformation of this MIR epitope are important for binding of mAb210 to neuronal AChRs.
Sedimentation of ␣6*AChRs on Sucrose Gradients. We have observed previously that, when expressed in X. laevis oocytes, ␣3␤2 AChRs sedimented on sucrose gradients as a uniform 11S component intermediate in size between monopentamers and dipentamers of T. californica electric organ ␣1 AChRs, whereas ␣6␤2 AChRs assembled efficiently to form epibatidine binding sites within the oocytes, but these sedimented as large amorphous aggregates (Kuryatov et al., 2000) . When expressed in HEK cells, the ␣6␤2 combination results in only small amounts of epibatidine binding sites, but most of these are on the cell surface (Fig. 1) . Most of these ␣6␤2 AChRs sediment as components larger than 11S (Fig. 5) , and substantial amounts pelleted in the centrifuge tube. Monopentamers were not clearly resolved from aggregates. Thus, ␣6␤2 AChRs do not efficiently form stable pentamers and may partially dissociate and aggregate. This disruption probably occurs during solubilization in Triton X-100, because the efficient expression of ␣6␤2 AChRs on the cell surface (Fig. 1C) suggests that in the membrane most were pentamers able to pass quality control analysis for exit from the endoplasmic reticulum and transport through the Golgi apparatus to the cell surface. Incorporation of the ␤3 subunit to form ␣6␤2␤3 AChRs not only results in assembly of many more AChRs (Fig. 1 ) but also most of these sediment as a component that is nearly the size of 9.5S T. californica AChR monopentamers (Fig. 5) . Thus, the presence of ␤3 accessory subunits permits the efficient assembly of stable pentameric AChRs. Both ␣6␤4 and ␣6␤4␤3 AChRs expressed in the cell lines sediment as a mixture of components corresponding to monopentamers and larger aggregates (Fig. 5) . The larger proportion of aggregates may bias the monopentamer peak to seem to sediment more rapidly than in the case of ␣6␤2␤3 AChRs. The formation of aggregates on sucrose gradients that is prominent with ␣6* AChRs is not observed with ␣1*, ␣3␤2, or ␣4␤2 AChRs (Kuryatov et al., 2000 (Kuryatov et al., , 2005 .
Agonist Binding to ␣6 AChRs. Figure 6 shows the concentration dependence of [ 3 H]epibatidine binding to all four ␣6* AChR subtypes. The K D for binding of epibatidine to ␣6␤2 AChRs (0.154 nM) was basically the same as the K D for binding to ␣6␤2␤3 AChRs (0.198 nM), ␣6␤4 AChRs (0.162 nM), or ␣6␤4␤3 AChRs (0.130 nM). This compares to the K D for binding of epibatidine to human ␣4␤2 AChRs similarly expressed and measured (0.017 nM) (Kuryatov et al., 2005) . Thus, the presence of ␤3 does not alter equilibrium binding affinity of ␣6␤2* or ␣6␤4* AChRs for epibatidine. All four ␣6* AChR subtypes exhibit much lower affinity for epibatidine than do ␣4␤2 AChRs.
Agonists were tested for their ability to inhibit the binding of [
3 H]epibatidine to fixed cells (Table 2 ). In general, the The cell lines expressing ␣3␤2 and ␣4␤2 AChRs were described previously Kuryatov et al., 2005) . A 0.5 nM concentration of AChRs and 1.5 nM ͓ 3 H͔epibatidine were used in these assays using triplicate samples. Reaction of mAbs to ␣6 and ␤3 with denatured subunits on blots. A, subunit specificity of the mAbs was demonstrated by dot blot assays using bacterially expressed human AChR subunit constructs. Reaction is compared with that of antiserum to each of the subunit constructs to demonstrate equal loading of the blots of all the subunits and thus the high specificity of the mAbs. B, specificity of the mAbs was further evaluated using Western blots of equal amounts of AChRs from HEK cell lines transfected with human ␣6␤4␤3, ␣3␤4␣5, or ␣4␤2 AChRs. The mAbs reacted strongly only with ␣6 subunits and not at all with the other subunits present. C, extent of expression of ␣6 subunits in the four ␣6* AChR cell lines was compared using an equal amount of protein from each line and mAb 349. mAbs were used at a 1/1000 dilution and 125 I-goat antimouse IgG purified antibodies were used at 2 nM. D, reaction of mAb 353 with chimeras (Kuryatov et al., 2000) consisting of the extracellular domains of ␣3 or ␣6 in combination with the remainder of the other of these subunits on Western blots. The transmembrane orientation of the epitopes of the ␣6 mAbs was determined using Western blots of equal amounts of chimeric AChRs from X. laevis oocytes injected with 25 ng per subunit of cRNA for the subunit combinations of ␣3/6␤2 or ␣6/ 3␤2. All six mAbs to ␣6 reacted strongly with chimeric ␣3/6 subunits and not at all with ␣6/3 subunits. Only the Western blot of mAb 353 is shown. molpharm.aspetjournals.org ␤2-containing ␣6* AChRs exhibited higher affinities for agonists. Cytisine discriminated by more than 7-fold in affinity between ␣6␤2* and ␣6␤4* AChRs. The affinity for nicotine is not significantly altered by the presence or absence of ␤3 subunits.
Both equilibrium binding studies of epibatidine (Fig. 6 ) and competitive binding studies with nicotine and other ligands (Table 2) indicate that the presence of ␤3 does not alter the ACh binding site or its affinity for nicotine. This is not surprising, because ␤3 assembles in the accessory position and is not part of an ACh binding site.
␤3 Greatly Increased Sensitivity of ␣6* AChRs to Nicotine-Induced Up-Regulation. Table 3 shows that the presence of ␤3 increased the sensitivity to nicotine-induced up-regulation of ␣6␤2␤3 by 11-fold compared with ␣6␤2 AChRs and of ␣6␤4␤3 AChRs by 6.6-fold compared with ␣6␤4 AChRs. The binding data of Fig. 6 and Table 2 show that the presence of ␤3 does not alter the ACh binding sites and greatly increases affinity for nicotine. So, how might ␤3 have such a large effect on nicotine-induced up-regulation? Nicotine probably acts on ␣6* AChRs as a molecular chaperone, as it does on ␣4␤2 AChRs (Kuryatov et al., 2005; Sallette et al., 2005) . Binding of nicotine to ␣6␤2␣6␤2 or ␣6␤4␣6␤4 assembly intermediates could produce activated or desensitized conformations that would assemble more efficiently with ␤3 than ␤2 or ␤4 subunits in the accessory position in a final assembly step to form mature pentamers. The greater AChR expression observed with ␤3-containing AChRs in the absence of nicotine (Fig. 1) shows that ␤3 promotes assembly of mature AChRs. On the other hand, nicotine could act as a molecular chaperone on ␣6␤2␤3 or ␣6␤4␤3assembly intermediates, and the presence of ␤3 could promote conformational changes to the active or desensitized conformations, which assemble more efficiently. The accessory subunit ␣5 influences the sensitivity to activation and desensitization of ␣3* AChRs (Gerzanich et al., 1998) .
The EC 50 for up-regulation by nicotine of ␣6␤2 AChRs (9.8 M) indicates that at the 0.1 to 0.2 M concentrations of nicotine sustained in the sera of cigarette smokers (Benowitz, 1996) , up-regulation of this subtype would be negligible. By contrast, the EC 50 for ␣6␤2␤3 (0.89 M) reveals that the presence of ␤3 confers an order of magnitude more sensitivity to nicotine-induced up-regulation, sufficient to suggest that some up-regulation might occur in a smoker. Still, the sensitivity is much less than that of human ␣4␤2 AChRs expressed in tsA201 HEK cells (EC 50 ϭ 0.039 M) (Kuryatov et al., 2005) , an AChR subtype that has much higher affinity for nicotine (K D ϭ 0.0028 M). ␤3 also increases the sensitivity to nicotine-induced up-regulation of ␣6␤4␤3 AChRs from EC 50 ϭ 3.55 M for ␣6␤4 AChRs to EC 50 ϭ 0.54 M for ␣6␤4␤3 AChRs.
Unlike human ␣3 AChRs expressed in HEK cell lines, where only ␤2-containing but not ␤4 containing AChRs are subject to nicotine-induced up-regulation , ␣6* AChRs containing either ␤2 or ␤4 subunits are sensitive to nicotine-induced up-regulation. The extent of up-regulation is greater for ␣6␤2␤3AChRs than for ␣6␤4␤3 AChRs, presumably reflecting the lower baseline assembly efficiency of ␤2 than ␤4 subunits Sallette et al., 2004) .
Culture at 29°C in Combination with Nicotine Dramatically Up-Regulates Expression of ␣6␤2 AChRs. Cooper et al. (1999) initially observed that culture at 30°C increased expression of ␣4␤2 AChRs and proposed that this resulted from increased assembly and/or slower turnover. The low amount of ␣6 subunits in the ␣6␤2 cell line by contrast with the large amount after transfection of this line with ␤3 (Fig. 3C) suggests that unassembled ␣6 and ␣6␤2 AChRs are unstable and that transfection with ␤3 promotes assembly and/or stabilizes the resulting AChRs. The large amount of ␣6 in the other lines shows that, if the AChRs are stabilized by the right subunit combination and ambient conditions, the ␣6 expression vector can result in substantial amounts of AChRs. Culture at 29°C increased the amount of ␣6␤2 AChRs to that obtained in the presence of ␤3, and it greatly increased the extent and sensitivity to nicotine-induced up-regulation, somewhat exceeding the effect of ␤3 on the amount of AChR (Fig. 7) . ␣6␤4 AChRs were expressed at a higher level than ␣6␤2 at 37°C, so the effects of culture at 29°C were substantial but less. In the presence of ␤3, there was little effect on nicotine-induced up-regulation of ␣6␤2␤3 AChRs and virtually none on ␣6␤4␤3 AChRs. These results are consistent with the idea that low temperature greatly increases the stability of ␣6␤2 assembly intermediates and AChRs, and it increases to a lesser extent the stability of the intrinsically more stable ␣6␤4 assembly intermediates and AChRs, while also promoting their assembly synergistically with the pharmacological chaperone effects of nicotine.
The differences in ␣6␤2 expression between HEK cells shown here and X. laevis oocytes (Kuryatov et al., 2000) demonstrate the importance of cell-specific factors on AChR assembly, and they suggest the possibility that in some cell Fig. 4 . Incorporation of ␤3 into ␣6* AChRs can be detected by immunodepletion using mAb 210 to the MIR. mAb 338 to ␣6 subunits was used to precipitate AChRs labeled with [ 3 H]epibatidine before and after adsorption with mAb 210 coupled with agarose. The labeled AChRs coupled to mAb 210-agarose were eluted and counted as well. mAb 210 was made to muscle AChR and binds to the MIR on ␣1 subunits, which includes a sequence similar to that on ␤3 subunits. mAb 210 agarose does not bind to ␣6␤2 or ␣6␤4 AChRs (data not shown). The values shown are mean Ϯ S.E.M. for triplicate samples. types (e.g., the aminergic neurons in which ␣6* AChRs are exclusively found in vivo) chaperone proteins might be able to produce effects equivalent to culture at 29°C.
Discussion
Four subtypes of human ␣6* AChRs (␣6␤2, ␣6␤2␤3, ␣6␤4, and ␣6␤4␤3) were stably expressed in human tsA201 HEK cell lines, and six mAbs to human ␣6 and one mAb to human ␤3 subunits were made to aid in the characterization of ␣6* AChRs. These ␣6mAbs were found to be directed at sequences C-terminal of the extracellular domain. These lines will permit more detailed studies of these AChR subtypes than is possible with brain neurons containing small amounts of complex mixtures of AChR subtypes. Even more complex ␣6* AChR subtypes such as ␣6␣4␤2␤3, which have been identified in brain and retina (Zoli et al., 2002; Champtiaux et al., 2003; Gotti et al., 2005a,b) , will also need to be studied in transfected cell lines. ␣6* AChRs are potential drug targets, for example, in Parkinson's disease (Quik and McIntosh, 2006) .
Host cell type influences the expression of AChRs, presumably as a reflection of differences the complement of chaperone proteins and enzymes for post-translational modification. For example, the chaperone protein Ric-3 is expressed in the human neuroblastoma cell line SH-SY5Y, which endogenously expresses ␣7 AChRs, but is not expressed in tsA201 HEK cells, which efficiently express transfected ␣7 AChRs only after cotransfection with Ric-3 (Landsdell et al., 2005; Williams et al., 2005) . ␣6* AChRs have only been reported in aminergic neurons, which may contain particular chaperones for the assembly and transport of ␣6* AChRs.
Expression of ␣6␤2 in X. laevis oocytes results in the formation of large amounts of epibatidine binding sites but no mature pentameric AChRs on the cell surface (Kuryatov et al., 2000) . Instead, ␣6 and ␤2 subunits form amorphous intracellular aggregates. In HEK cells only small amounts of ␣6␤2 AChRs are made, but a large proportion are on the cell surface. ␣6 is closely related in sequence to ␣3 (Lindstrom, 2000; Le Novere et al., 2002) . ␣3␤2 forms functional AChRs in oocytes (Gerzanich et al., 1998) . In tsA201 HEK cell lines, ␣3␤2 expresses less well than does ␣3␤4 , resembling the relationship between ␣6␤2 and ␣6␤4. In HEK cell lines, ␣3␤2 is greatly up-regulated by nicotine but human ␣3␤4 is not . ␣6␤4 is up-regulated by nicotine. Thus, there are both cell type and subunit-specific factors that influence expression.
Culture at 29°C dramatically increases the expression of ␣6␤2 and its sensitivity to up-regulation by nicotine but has a smaller effect on ␣6␤4 (that is intrinsically expressed at a higher level). The low temperature apparently greatly stabilizes ␣6␤2 AChRs or their assembly intermediates, permitting the accumulation of large amounts under the influence of nicotine. Nicotine probably acts as a pharmacological chaperone (Kuryatov et al., 2005; Corringer et al., 2006) . In HEK cells, nicotine dramatically increases the amount of ␣3␤2 AChRs (22-fold) without causing a dramatic increase (perhaps 2-fold) in the amount of ␣3 subunits on Western blots , indicating that, as in an ␣4␤2 line I-␣-bungarotoxin. Arrows indicate the positions of the peaks corresponding to the 9.5S monomers and 13S dimers of T. californica AChRs. ␣6␤2 and ␣6␤2␤3 AChRs were isolated on microwells coated with mAb 295 to ␤2 subunits. ␣6␤4 and ␣6␤4␤3 AChRs were isolated on microwells coated with mAb 338 to ␣6 subunits. Isolated ␣6* AChRs were labeled with [
3 H]epibatidine. mAb 338 to ␣6 and mAb 337 to ␤4 subunits (Nelson et al., 2001) were equally effective when coated on microwells at adsorbing ␣6␤4 and ␣6␤4␤3 AChRs. However, mAb 338 was much less effective at adsorbing ␣6␤2 and ␣6␤2␤3 AChRs. Thus, mAb 295-coated wells were used. The epitope for mAb 338 is probably near the subunit interface and influenced by the ␤ subunit present. The sucrose gradients shown were representative of several similar gradients analyzed. (Kuryatov et al., 2005) , there are large pools of unassembled ␣3 subunits present. By contrast, Western blots of ␣6␤2 reveal that only small amounts of ␣6 are present, even though transfection of this line with ␤3 results in much larger amounts of ␣6, and parallel ␣6␤4 and ␣6␤4␤3 lines contain much more ␣6. Thus, unassembled ␣6 as well as ␣6␤2 AChRs must be relatively unstable. Using chimeras between ␣6 and ␣3 or ␣4 subunits, the part of the ␣6 subunit that limits expression of mature AChRs with ␤2 in X. laevis oocytes was mapped to sequences C-terminal of the extracellular domain of ␣6 (Kuryatov et al., 2000) . In ␣6* AChRexpressing neurons, there may be chaperones that have effects similar to culture at 29°C in promoting the assembly and stability of ␣6␤2 AChRs.
The presence of ␤3 in the accessory position greatly increased expression of ␣6␤2 and ␣6␤4, increased sensitivity to up-regulation by nicotine, and negated any additional effect of culture at 29°C. In these respects, the effects of ␤3 were more dramatic than the effects of ␣5 on ␣3 AChRs (Gerzanich et al., 1998; Wang et al., 1998) . The effects of temperature, nicotine, and subunit composition suggest that regulation of AChR expression in these cell lines occurs primarily at the post-translational level. Studies of the amount of AChR ␣4 and ␤2 subunit protein in the brains of AChR subunit knockout mice similarly demonstrate that in brain, the regulation of AChR expression also occurs primarily at the posttranslational level (Whiteaker et al., 2006) . In X. laevis oocytes (Peng et al., 1994) , HEK cells (Kuryatov et al., 2005) , and rodent brain (Flores et al., 1992) , nicotine-induced upregulation of ␣4␤2 AChRs occurs by post-translational mechanisms.
The complete aggregation of ␣6␤2 AChRs expressed in X. laevis oocytes (Kuryatov et al., 2000) and extensive aggregation of ␣6* AChR subtypes expressed in HEK cells suggest that this reflects a particular property of ␣6 subunits. The detergent Triton X-100 used for solubilization may partially dissociate some ␣6 AChR subtypes and subsequent reaggregation might account for the sedimentation properties observed. The presence of ␤3 greatly increased the proportion of monopentamers in ␣6␤2␤3 AChRs compared with ␣6␤2 AChRs, perhaps by stabilizing them against dissociation. It will be interesting to determine whether substitution of one of the two ␣6 subunits in an AChR pentamer by an ␣4 or ␣3 subunit to produce the most abundant and complex subtypes of brain ␣6* AChRs might reduce or eliminate aggregation of the resulting AChRs, reflecting a stabilizing influence on pentamers.
The presence of ␤3 subunits increased sensitivity to upregulation by nicotine of ␣6* AChRs to the range where the 0.1 to 0.2 M concentration of nicotine sustained in the sera of cigarette smokers (Benowitz, 1996) would be expected to cause some up-regulation of these ␣6* AChR subtypes in brain. However, these ␣6* AChRs are much less sensitive to up-regulation than are ␣4␤2 AChRs (Kuryatov et al., 2005) . Parker et al. (2004) reported selective up-regulation of ␣6␤2 AChRs compared with ␣4␤2 AChRs in rat brain as a result of long-term self-administration of nicotine. On the contrary, reduction in the amount of ␣6* AChRs after nicotine treatment in various other ways has been reported in rats, mice, and monkeys (Lai et al., 2005; McCallum et al., 2006; Mugnaini et al., 2006) . How can these apparently contradictory results on the ability of nicotine to up-regulate ␣6* AChRs be explained? Dopaminergic neurons in the ventral tegmental area of rodents express a mixture of ␣4, ␣6, ␤2, and ␤3 subunits and preferentially transport ␣4␣6␤2␤3 to their nerve endings in the striatum but express ␣4␤2 AChRs on the cell bodies (Zoli et al., 2002; Champtiaux et al., 2003; Gotti et al., 2005b; Quik et al., 2005) . In primates, ␣3 subunits are also involved, and there is a lower proportion of ␣4␤2 in the endings. In monkey striatum, 70% of nicotineevoked dopamine release is mediated by ␣6␤2* and/or ␣3␤2* AChRs, whereas in rodents ␣6␤2* AChRs mediate only 30% (Quik and McIntosh, 2006) . This complex mixture of AChRs subunits competes for assembly in the endoplasmic reticulum of these neurons. Nicotine acts as a molecular chaperone to promote assembly of AChRs by binding to assembly intermediates (Kuryatov et al., 2005; Sallette et al., 2005; Corringer et al., 2006) . The mean plasma nicotine concentration in monkeys given nicotine in their drinking water was 51 nM (McCallum et al., 2006) . This would efficiently promote upregulation of human ␣4␤2 AChRs expressed in HEK cells (EC 50 ϭ 35 nM; Kuryatov et al., 2005) , but it would have little effect on ␣6␤2␤3 AChRs (EC 50 ϭ 890 nM). If the amount of ␤2 subunits were limiting, at low nicotine concentrations, increased assembly of ␣4␤2 AChRs could decrease assembly of ␣6␤2␤3 AChRs by depleting the pool of ␤2 subunits. Nicotine-induced slowing of mature AChR destruction (Kuryatov et al., 2005) could also up-regulate AChRs in nerve endings as well as on the cell body. Up-regulation by this molpharm.aspetjournals.org mechanism might also selectively affect high affinity ␣4␤2* AChRs. Most nicotine-induced brain AChR up-regulation is of highly sensitive ␣4␤2 AChRs (Flores et al., 1992) . Autonomic ganglia express a mixture of ␣3, ␤2, ␤4, and ␣5 subunits but preferentially assemble ␣3␤4 AChRs (DavilaGarcia et al., 2003; Nguyen et al., 2003) . The nicotine concentrations obtained in vivo result in negligible up-regulation of the less sensitive ␣3* AChRs. The large increase in amount of ␣6* AChRs as well as their sensitivity to nicotine-induced up-regulation that results from the ␤3 subunit is consistent with the hypothesis that assembly of the ␤3 subunit in the accessory position is the final step in assembly of mature AChRs. The ␤3 subunit seems to preferentially assemble in the accessory position over ␤2 or ␤4 to result in larger amounts of AChRs. ␤3-containing ␣6 AChRs did not show increased affinity for nicotine. The increased sensitivity to up-regulation by nicotine in the presence of ␤3 could result from assembly intermediates such as ␣6␤2 or ␣6␤2␣6␤2, assuming a nicotineinduced desensitized conformation that more efficiently assembles with ␤3. On the other hand, assembly intermediates incorporating ␤3, such as ␤3␣6␤2, could more efficiently assume a nicotine-induced conformation that assembles more efficiently.
